Gene · 2160
Papers2,705
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,705
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-Cell Transcriptomic Profiling Reveals Cellular Heterogeneity and Identifies Novel Therapeutic Targets in Osteosarcoma. | Int J Genomics | 2026 | 42472256 | PubTator, text mining | PubMed |
| Molecular and clinical characterization of a pedigree with factor XI deficiency, including a novel missense variant (p.Cys200Phe): a case report. | J Med Case Rep | 2026 | 42449417 | PubTator, text mining | PubMed |
| Integrative proteogenomic analyses identify plasma proteins that impact the risk of ischemic stroke. | Commun Med (Lond) | 2026 | 42399650 | PubTator, text mining | PubMed |
| Anti-TFPI Single-Domain Antibodies: Novel Rebalancing Therapies for Hemophilia and Other Rare Bleeding Disorders. | Thromb Haemost | 2026 | 42379253 | PubTator, text mining | PubMed |
| Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning. | Curr Opin Hematol | 2026 | 42348666 | PubTator, text mining | PubMed |
| Genomic diagnosis and multisystem phenotyping in pediatric congenital analbuminemia: clinical, coagulation, and immune signatures. | Front Pediatr | 2026 | 42311911 | PubTator, text mining | PubMed |
| Prognostic significance of coagulation factor activity in acute stroke: a retrospective cohort study. | Front Med (Lausanne) | 2026 | 42292201 | PubTator, text mining | PubMed |
| Emerging strategies in venous thromboembolism: a narrative review of pharmacological innovations. | Thromb J | 2026 | 42260521 | PubTator, text mining | PubMed |
| Clinical characteristics and IgE-binding protein profiles of patients with buckwheat allergy in China. | World Allergy Organ J | 2026 | 42256020 | PubTator, text mining | PubMed |
| Intrinsic activated thrombin generation for treatment efficacy and monitoring of octocog alfa and emicizumab in severe hemophilia A. | Res Pract Thromb Haemost | 2026 | 42254461 | PubTator, text mining | PubMed |
| Huo-Xue-Xiao-Zhong Decoction prevents thrombus formation of deep vein thrombosis by targeting SOAT2 to modulate the AKT and ERK pathways. | J Ethnopharmacol | 2026 | 42252035 | PubTator, text mining | PubMed |
| [Analysis of Emerging Gene Variant and Molecular Mechanism Study of a Patient with Inherited FXI Deficiency]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2026 | 42227448 | PubTator, text mining | PubMed |
| A comprehensive multicenter study assessing the impact of abelacimab, asundexian, and milvexian on coagulation assays. | Blood Adv | 2026 | 42200460 | PubTator, text mining | PubMed |
| An Iron-Complement Network Model of Thromboinflammation and Humoral Immune Remodeling in Severe COVID-19. | Curr Issues Mol Biol | 2026 | 42193140 | PubTator, text mining | PubMed |
| Factor XI as a risk factor for persistent left ventricular thrombus following acute myocardial infarction. | Kardiol Pol | 2026 | 42153773 | PubTator, text mining | PubMed |
| Pharmacologic Factor XI/XIa Inhibitors: What the Laboratory Hematologist Needs to Know. | Clin Lab Med | 2026 | 42140683 | PubTator, text mining | PubMed |
| Abdominal Fat Measures Are Associated With Sex-Specific Prothrombotic Changes in Middle-Aged Adults. | Arterioscler Thromb Vasc Biol | 2026 | 42131917 | PubTator, text mining | PubMed |
| Prothrombotic genetic variants and cancer-associated venous thromboembolism: defining thrombotic risk across tumor types. | Haematologica | 2026 | 42095241 | PubTator, text mining | PubMed |
| The in vitro anticoagulant effect of abelacimab in healthy children. | Res Pract Thromb Haemost | 2026 | 42023398 | PubTator, text mining | PubMed |
| Coagulation factor XI as a protector against heart failure: Diverse effects and potential threats. | Kardiol Pol | 2026 | 41972897 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2160/papers?page=2